Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Sellers

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Drugs|October 9, 2012
Pharmacy compounding primer for physicians: prescriber bewareSarah Sellers, Wulf H Utian
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Safety analysis of fidaxomicin in comparison with oral vancomycin for Clostridium difficile infectionsKarl Weiss, Robin L Allgren, Sarah Sellers
Frontiers in Drug Safety and Regulation|December 17, 2025
The use of observed-to-expected analyses as a signal detection tool in COVID-19 vaccine safety surveillance: lessons learned from an industry perspectiveLaurence Serradell, Antonella Fretta, Jenny Nachbar, et al.
Expert Review of Vaccines|March 12, 2026
Safety of Matrix-M-adjuvanted COVID-19, seasonal influenza, combination influenza-COVID-19, and malaria vaccines: a review of the evidenceJonathan Fix, Sandra Lee, Jenny Nachbar, et al.
Vaccine|March 19, 2013
Template protocol for clinical trials investigating vaccines--focus on safety elementsJan Bonhoeffer, Egeruan B Imoukhuede, Grace Aldrovandi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Drugs|October 9, 2012
Pharmacy compounding primer for physicians: prescriber bewareSarah Sellers, Wulf H Utian
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Safety analysis of fidaxomicin in comparison with oral vancomycin for Clostridium difficile infectionsKarl Weiss, Robin L Allgren, Sarah Sellers
Frontiers in Drug Safety and Regulation|December 17, 2025
The use of observed-to-expected analyses as a signal detection tool in COVID-19 vaccine safety surveillance: lessons learned from an industry perspectiveLaurence Serradell, Antonella Fretta, Jenny Nachbar, et al.
Expert Review of Vaccines|March 12, 2026
Safety of Matrix-M-adjuvanted COVID-19, seasonal influenza, combination influenza-COVID-19, and malaria vaccines: a review of the evidenceJonathan Fix, Sandra Lee, Jenny Nachbar, et al.
Vaccine|March 19, 2013
Template protocol for clinical trials investigating vaccines--focus on safety elementsJan Bonhoeffer, Egeruan B Imoukhuede, Grace Aldrovandi, et al.
Pageof 1